Cereno Scientific
Manufacturing · Sweden · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Förändringens Gata 10, Moelndal, Vaestra...Phone Number
+46 732366246Website
www.cerenoscientific.comRevenue
-Stock Symbol
CRNOIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Cereno Scientific
Cereno Scientific AB , a clinical stage biotechnology company, develops therapeutics to treat cardiovascular and pulmonary diseases worldwide. The company's lead drug candidate is CS1, a product candidate that is in phase II clinical trial for the treatment of rare disease pulmonary arterial hypertension, as well as a histone deacetylase (HDAC) inhibitor that acts as an epigenetic modulator with pressure-reducing, reverse-remodeling, anti-inflammatory, anti-fibrotic, and antithrombotic properties.Explore more
Cereno Scientific Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Cereno Scientific your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Cereno Scientific
Earning: See what the market has to say on Cereno Scientific recently announced quarterly report
Click to see if Cereno Scientific had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Cereno Scientific has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Cereno Scientific, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Cereno Scientific launches new products
Check if Cereno Scientific has recently received funding, and reach out quickly before it becomes old news!
Check out if Cereno Scientific is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Cereno Scientific as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Cereno Scientific is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Cereno Scientific is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Cereno Scientific.
Cereno Scientific financials insights
Gather financial insights about Cereno Scientific, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Debt
$22.8M
2025
Debt
$10M
Cereno Scientific Tech Stack
A closer look at the technologies used by Cereno Scientific
See more technologies
Most Recent Scoops
Funding
Funding
Funding
Funding
Project
Research & Development, Intellectual Property
Project
Product Development, Research & Development, Intellectual Property
Project
Product Development, Intellectual Property, Legal Affairs
Cereno Scientific News & Media
Cereno Scientific Reports Favorable Safety and Tolerability after 12 Months of CS1 Treatment in PAH from the Expanded Access Program
GOTHENBURG, Sweden, March 31, 2026 /PRNewswire/ -- Cereno Scientific (NASDAQ First North: CRNO B), an innovative biotech pioneering treatments to enhance and extend life for people with rare cardiovascular and pulmonary diseases, today announced initial learnings from the 12-month...Cereno Scientific Receives Approval to Initiate FDA-aligned Phase I Pharmacokinetic Study of CS014 Supporting Phase II Development in PH-ILD
GOTHENBURG, Sweden, March 17, 2026 /PRNewswire/ -- Cereno Scientific (NASDAQ First North: CRNO B), an innovative biotech pioneering treatments to enhance and extend life for people with rare cardiovascular and pulmonary diseases, today announced that the Swedish Medical Products Agency...Cereno Scientific Receives Approval to Initiate FDA-aligned Phase I Pharmacokinetic Study of CS014 Supporting Phase II Development in PH-ILD
GOTHENBURG, Sweden, March 17, 2026 /PRNewswire/ -- Cereno Scientific (NASDAQ First North: CRNO B), an innovative biotech pioneering treatments to enhance and extend life for people with rare cardiovascular and pulmonary diseases, today announced that the Swedish Medical Products Agency...Cereno Scientific broadens development focus for CS014 to pulmonary hypertension associated with interstitial lung disease
GOTHENBURG, Sweden, Feb. 4, 2026 /PRNewswire/ -- Cereno Scientific (NASDAQ First North: CRNO B), an innovative biotech pioneering treatments to enhance and extend life for people with rare cardiovascular and pulmonary diseases, today announced that it is broadening the development focus...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cereno Scientific
Sign Up For FreeTo access detailed company insights
Cereno Scientific AB , a clinical stage biotechnology company, develops therapeutics to treat cardiovascular and pulmonary diseases worldwide. The company's lead drug candidate is CS1, a product candidate that is in phase II clinical trial for the treatment of rare disease pulmonary arterial hypertension, as well as a histone deacetylase (HDAC) inh... Read More
